Anemia
📧 Sign up to get email alerts when something new happens for Anemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Luspatercept for Clonal Cytopenias of Uncertain Significance [Phase 2]
The entry notes an ongoing Phase 2 trial of luspatercept for clonal cytopenias of uncertain significance (CCUS) and related cytopenias such …
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: The Association Between Anemia and Cardiomegaly
A completed clinical trial investigating the association between anemia and cardiomegaly.
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia [Phase 2]
Phase 2 study to assess the efficacy and safety of luspatercept in adults with alpha-thalassemia, with safety and pharmacokinetics in adoles…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women [Phase 4]
Phase 4 clinical trial comparing the efficacy and tolerability of Sucrosomial Iron versus Ferric Maltol in iron-deficient women with iron de…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections [Phase 3]
Phase 3 trial update for the INTERCEPT Blood System for Red Blood Cells in regions at risk for Zika virus transfusion-transmitted infections…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) [Phase 2, Phase 3]
This document reports an ongoing Phase 2/Phase 3 clinical trial evaluating pazopanib for hereditary hemorrhagic telangiectasia-related epist…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor [Phase 1, Phase 2]
Phase 1/2 first-in-human trial evaluating ALN-CFB, an siRNA against complement factor B, for adults with paroxysmal nocturnal hemoglobinuria…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Effects of SGLT2 Inhibitors on Erythropoiesis in Heart Failure
A clinical trial is investigating how SGLT2 inhibitors affect erythropoiesis in people with heart failure, with active but not recruiting st…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study [Phase 3]
Phase 3 clinical trial PALaDIN compares high-dose versus low-dose iron therapy to treat anemia in people on peritoneal dialysis; recruitment…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease [Phase 1, Phase 2]
This clinical trial update describes ongoing Phase 1 and Phase 2 studies evaluating BMS-986470 in healthy volunteers and participants with s…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Genomic of CONgenital Sideroblastic Anemias [NA]
A recruiting clinical trial in Amiens, France is investigating genomic approaches to congenital sideroblastic anemia.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: The Influence of Anemia on HbA1c Readings in Non-Diabetic Patients
This clinical trial update investigates how anemia may influence HbA1c test results in non-diabetic individuals.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions [Phase 3]
A Phase 3 clinical trial compares elritercept with epoetin alfa to treat anemia in adults with very low-, low-, or intermediate-risk myelody…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia [Phase 1, Phase 2]
Ongoing Phase 1/2 study of DISC-0974 (RALLY-MF) in patients with myelofibrosis and anemia; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Guideline Adherence for Preoperative Anemia Management in a PAC
A Siriraj Hospital-sponsored clinical trial is recruiting to assess adherence to guidelines for preoperative anemia management in a PAC sett…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: The Efficacy and Safety of Luspatercept in Improving Early Anemia After HSCT [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of luspatercept to improve early anemia after hematopoietic stem cell transplantat…
-
EMA approval · 2026-03-02EMA Authorised: Retacrit (epoetin zeta) — Pfizer Europe MA EEIG
EMA authorised Retacrit (epoetin zeta) as a biosimilar epoetin for the treatment of anemia in chronic kidney disease and cancer, among other…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia [Phase 1]
Phase 1 trial evaluating the safety of a multi-agent regimen (CDX-1401, Poly ICLC, Decitabine, and Nivolumab) in patients with myelodysplast…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Treatment and Prevention of Severe Anemia in Pregnant Zanzibari Women [Phase 3]
Phase 3 clinical trial update from Cornell University on the treatment and prevention of severe anemia in pregnant Zanzibari women; the stud…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Quality of Life-Guided Transfusion in Refractory MDS or AML [NA]
A clinical trial evaluating quality-of-life-guided transfusion in adults with refractory myelodysplastic syndromes or acute myeloid leukemia…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respect to HAS 2014 Recommendations
A completed clinical trial characterizes very preterm and extremely preterm infants who received excess erythrocyte transfusions in relation…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma
This recruiting study from the University of Florida investigates brain–bone marrow–gut interactions after major trauma and how these system…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: RBC Irradiation, Anemia and Gut Injury
Emory University is conducting a clinical study on red blood cell irradiation for anemia and gut injury, with the trial currently active but…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) [Phase 2]
A Takeda-sponsored Phase 2 trial evaluating Elritercept for treating anemia in adults with very low, low, or intermediate-risk myelodysplast…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigates repurposing the HIV drug Nelfinavir to improve iron delivery to the bone marrow in patients with mye…